Carregant...
Enhancement of oral bioavailability of doxorubicin through surface modified biodegradable polymeric nanoparticles
BACKGROUND: Doxorubicin hydrochloride (DOX·HCl), an anthracycline glycoside antibiotic, exhibits low oral bioavailability due to active efflux from intestinal P-glycoprotein receptors. The oral administration of DOX remains a challenge hence; no oral formulation for DOX is marketed, till date. AIM O...
Guardat en:
| Publicat a: | Chem Cent J |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer International Publishing
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5966352/ https://ncbi.nlm.nih.gov/pubmed/29796830 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13065-018-0434-1 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|